Single signal · #9207

$KNSA — AI Filing Signal

Public delayed archive entry for this Stock Catalyst AI alert.

? All delayed signals

$KNSA – Kiniksa Reports Strong Q3 2026: Revenue +58%, Net Income Surges, Full-Year Guidance Raised

Kiniksa Pharmaceuticals International, plc
· SEC_8K · All $KNSA
?? Positive AI Sentiment (+7.5 / 10)
  • Total Q3 2026 revenue rose ~58% YoY to $286.0M vs $180.9M in Q3 2025.
  • Net income increased significantly to $47.3M compared to $18.4M in prior-year quarter.
  • Raised 2026 ARCALYST sales guidance to $1.045B–$1.050B from prior $980M–$995M.